Survey on Orally Disintegrating Tablets

Evaluation of satisfaction with orally disintegrating tablets in non-elderly people with type 2 diabetes based on a web survey linked to receipt data

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030230612

Enrollment

400

Registered

2024-02-01

Start date

2024-02-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - People who registered in Pep Up, a PHR service for health insurance societies, provided by JMDC - People who have consented to participate in this research Of these, the primary and secondary outcome analysis populations are people who have used orally disintegrating tablets and are confirmed to be people with type 2 diabetes. The target sample size of these people is 400.

Exclusion criteria

Exclusion criteria: - People who belong to the health insurance society of Mitsubishi Tanabe Pharma - People who belong to the health insurance society that do not participate in this research

Design outcomes

Primary

Measure	Time frame
Percentage of people satisfied with orally disintegrating tablets in non-elderly people with type 2 diabetes	—

Secondary

Measure	Time frame
Odds Ratio of factors for satisfaction/dissatisfaction with orally disintegrating tablets in non-elderly people with type 2 diabetes	—

Contacts

Public Contactinformation desk JMDC

JMDC Inc.

phw-op@jmdc.co.jp+81-3-5733-8614

Outcome results